Atlas Trials

Health-Related Quality of Life Outcomes in Patients With Aggressive B-Cell Lymphomas Treated With CAR-T Cell Therapy in Real Life

Clinical trial NCT06026644 · COMPLETED

Trial details

NCT number
NCT06026644
Sponsor
Gruppo Italiano Malattie EMatologiche dell'Adulto
Status
COMPLETED
Study type
OBSERVATIONAL
DLBCL - Diffuse Large B Cell Lymphoma
Start date
2022-06-29
Primary completion
2024-02-15
Enrollment
170

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.